Sibannac Inc
Sibannac, Inc. operates as a media and management services company. It serves businesses with online marketing, advertising, sales tracking, management consulting, and other informational services. The company also provides accounting, and expense and labor management systems to assist in compliance in the regulated industry environment. Sibannac, Inc. is based in Phoenix, Arizona.
Sibannac Inc (SNNC) - Net Assets
Latest net assets as of November 2025: $-556.15K USD
Based on the latest financial reports, Sibannac Inc (SNNC) has net assets worth $-556.15K USD as of November 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($764.04K) and total liabilities ($1.32 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-556.15K |
| % of Total Assets | -72.79% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 1044.56 |
Sibannac Inc - Net Assets Trend (2011–2024)
This chart illustrates how Sibannac Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Sibannac Inc (2011–2024)
The table below shows the annual net assets of Sibannac Inc from 2011 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-08-31 | $-724.71K | -2515.46% |
| 2023-08-31 | $30.00K | -87.10% |
| 2022-08-31 | $232.65K | +119.14% |
| 2021-08-31 | $-1.22 Million | +2.90% |
| 2020-08-31 | $-1.25 Million | +54.43% |
| 2019-08-31 | $-2.75 Million | -838.17% |
| 2016-08-31 | $-292.83K | -603.23% |
| 2015-08-31 | $58.19K | +177.77% |
| 2014-08-31 | $-74.82K | +83.41% |
| 2013-08-31 | $-451.15K | -812.37% |
| 2011-08-31 | $-49.45K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Sibannac Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 534944800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (August 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $109.65K | % |
| Other Comprehensive Income | $75.96K | % |
| Other Components | $4.62 Million | % |
| Total Equity | $-724.71K | 100.00% |
Sibannac Inc Competitors by Market Cap
The table below lists competitors of Sibannac Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Kanabo Group PLC
LSE:KNB
|
$173.13 |
|
DDMP REIT Inc
PSE:DDMPR
|
$174.24 |
|
WEMA BANK PLC
XNSA:WEMABANK
|
$174.38 |
|
Sadhana Nitro Chem Limited
NSE:SADHNANIQ
|
$175.03 |
|
Providence Resources Inc
PINK:PVRS
|
$172.96 |
|
Viaderma Inc
PINK:VDRM
|
$172.76 |
|
LSE Capital Limited
KAR:LSECL
|
$172.31 |
|
Zoglo's Food Corp.
F:G8I
|
$172.20 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Sibannac Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 30,003 to -724,711, a change of -754,714 (-2515.5%).
- Net loss of 755,000 reduced equity.
- Other factors increased equity by 286.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-755.00K | -104.18% |
| Other Changes | $286.00 | +0.04% |
| Total Change | $- | -2515.46% |
Book Value vs Market Value Analysis
This analysis compares Sibannac Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-08-31 | $-0.01 | $0.02 | x |
| 2013-08-31 | $-0.09 | $0.02 | x |
| 2014-08-31 | $-0.02 | $0.02 | x |
| 2015-08-31 | $0.00 | $0.02 | x |
| 2016-08-31 | $-0.02 | $0.02 | x |
| 2019-08-31 | $-0.17 | $0.02 | x |
| 2020-08-31 | $-0.08 | $0.02 | x |
| 2021-08-31 | $-0.05 | $0.02 | x |
| 2022-08-31 | $0.00 | $0.02 | x |
| 2023-08-31 | $0.00 | $0.02 | x |
| 2024-08-31 | $-0.01 | $0.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Sibannac Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -25166.67%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-521.66%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 0.00% | -5.74% | 4.21x | 0.00x | $-56.75K |
| 2013 | 0.00% | -81.04% | 1.03x | 0.00x | $-122.88K |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $-273.30K |
| 2015 | -4079.74% | 0.00% | 0.00x | 9.71x | $-2.38 Million |
| 2016 | 0.00% | -67.03% | 1.62x | 0.00x | $-321.72K |
| 2019 | 0.00% | -535.14% | 0.86x | 0.00x | $-22.28K |
| 2020 | 0.00% | -142.43% | 1.49x | 0.00x | $-238.08K |
| 2021 | 0.00% | -359.80% | 0.17x | 0.00x | $-444.43K |
| 2022 | -254.87% | -9243.29% | 0.01x | 3.79x | $-616.22K |
| 2023 | -1403.68% | -97038.02% | 0.00x | 39.30x | $-424.15K |
| 2024 | 0.00% | -25166.67% | 0.00x | 0.00x | $-682.53K |
Industry Comparison
This section compares Sibannac Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $439,452,927
- Average return on equity (ROE) among peers: -31.68%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Sibannac Inc (SNNC) | $-556.15K | 0.00% | N/A | $173.00 |
| Ascend Wellness Holdings Inc (AAWH) | $71.80 Million | -118.37% | 11.54x | $48.90 Million |
| AB Science S.A (ABSCF) | $-21.01 Million | 0.00% | 0.00x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $-294.68K | 0.00% | 0.00x | $603.58K |
| Aurora Cannabis Inc (ACB) | $521.74 Million | -156.52% | 0.78x | $195.20 Million |
| Acreage Holdings Inc (ACRDF) | $494.79 Million | -30.37% | 0.40x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $29.91 Million | 0.00% | 0.07x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.72 Million | -18.78% | 0.11x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $20.08 Million | -10.91% | 0.33x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $21.19 Million | 12.93% | 1.96x | $1.85 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.25 Billion | 5.19% | 0.72x | $85.61 Million |